Korea Investment Corp
BMY icon

Korea Investment Corp’s Bristol-Myers Squibb BMY Stock Holding History

Korea Investment Corp’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$103M Buy
1,703,989
+209,534
+14% +$12.2M 0.21% 81
2025
Q4 		$80.6M Buy
1,494,455
+115,975
+8% +$5.58M 0.16% 114
2025
Q3 		$62.2M Sell
1,378,480
-265,565
-16% -$12.4M 0.13% 155
2025
Q2 		$76.1M Sell
1,644,045
-393,981
-19% -$19.3M 0.17% 118
2025
Q1 		$124M Buy
2,038,026
+39,394
+2% +$2.3M 0.3% 64
2024
Q4 		$113M Buy
1,998,632
+9,567
+0.5% +$535K 0.27% 69
2024
Q3 		$103M Buy
1,989,065
+741,172
+59% +$34.8M 0.24% 84
2024
Q2 		$51.8M Sell
1,247,893
-390,588
-24% -$17.5M 0.13% 144
2024
Q1 		$88.9M Sell
1,638,481
-30,638
-2% -$1.56M 0.23% 91
2023
Q4 		$85.6M Buy
1,669,119
+47,326
+3% +$2.48M 0.22% 99
2023
Q3 		$94.1M Sell
1,621,793
-10,598
-0.6% -$649K 0.28% 78
2023
Q2 		$104M Sell
1,632,391
-89,992
-5% -$6.03M 0.29% 74
2023
Q1 		$119M Buy
1,722,383
+96,274
+6% +$6.79M 0.35% 66
2022
Q4 		$117M Sell
1,626,109
-424,252
-21% -$32M 0.37% 61
2022
Q3 		$146M Sell
2,050,361
-84,718
-4% -$6.15M 0.45% 45
2022
Q2 		$164M Buy
2,135,079
+302,477
+17% +$23M 0.5% 36
2022
Q1 		$134M Buy
1,832,602
+373,317
+26% +$25.1M 0.33% 72
2021
Q4 		$91M Buy
1,459,285
+116,201
+9% +$6.82M 0.24% 119
2021
Q3 		$79.5M Sell
1,343,084
-227,030
-14% -$15M 0.24% 112
2021
Q2 		$105M Sell
1,570,114
-123,757
-7% -$8.07M 0.3% 88
2021
Q1 		$107M Sell
1,693,871
-33,353
-2% -$2.08M 0.34% 73
2020
Q4 		$107M Sell
1,727,224
-96,809
-5% -$5.95M 0.32% 77
2020
Q3 		$110M Sell
1,824,033
-167,700
-8% -$10.1M 0.39% 60
2020
Q2 		$117M Buy
1,991,733
+316,300
+19% +$18.9M 0.43% 51
2020
Q1 		$93.4M Sell
1,675,433
-246,600
-13% -$15.1M 0.41% 53
2019
Q4 		$123M Buy
1,922,033
+648,351
+51% +$37.1M 0.45% 47
2019
Q3 		$64.6M Sell
1,273,682
-4,300
-0.3% -$202K 0.27% 93
2019
Q2 		$58M Buy
1,277,982
+58,700
+5% +$2.73M 0.25% 103
2019
Q1 		$58.2M Sell
1,219,282
-133,191
-10% -$6.63M 0.26% 94
2018
Q4 		$70.3M Buy
1,352,473
+44,400
+3% +$2.39M 0.38% 60
2018
Q3 		$81.2M Buy
1,308,073
+95,880
+8% +$5.69M 0.37% 61
2018
Q2 		$67.1M Sell
1,212,193
-165,300
-12% -$8.93M 0.31% 78
2018
Q1 		$87.1M Sell
1,377,493
-13,038
-0.9% -$839K 0.4% 58
2017
Q4 		$85.2M Buy
1,390,531
+206,100
+17% +$12.9M 0.39% 62
2017
Q3 		$75.5M Buy
1,184,431
+43,380
+4% +$2.53M 0.35% 62
2017
Q2 		$63.6M Buy
1,141,051
+70,321
+7% +$3.83M 0.3% 74
2017
Q1 		$58.2M Sell
1,070,730
-508,732
-32% -$27.9M 0.29% 74
2016
Q4 		$92.3M Buy
1,579,462
+22,672
+1% +$1.24M 0.44% 51
2016
Q3 		$83.9M Buy
1,556,790
+84,270
+6% +$5.41M 0.45% 51
2016
Q2 		$108M Buy
1,472,520
+322,100
+28% +$22.8M 0.64% 29
2016
Q1 		$73.5M Buy
1,150,420
+100
+0% +$6.31K 0.54% 36
2015
Q4 		$79.1M Buy
1,150,320
+88,400
+8% +$5.84M 0.55% 34
2015
Q3 		$62.9M Buy
1,061,920
+201,720
+23% +$12.8M 0.5% 39
2015
Q2 		$57.2M Sell
860,200
-169,200
-16% -$11.2M 0.49% 38
2015
Q1 		$66.4M Buy
1,029,400
+257,900
+33% +$16.1M 0.52% 38
2014
Q4 		$45.5M Sell
771,500
-128,400
-14% -$7.24M 0.37% 57
2014
Q3 		$46.1M Sell
899,900
-46,000
-5% -$2.3M 0.38% 53
2014
Q2 		$45.9M Sell
945,900
-400
-0% -$19.7K 0.38% 52
2014
Q1 		$49.2M Buy
946,300
+341,400
+56% +$18.2M 0.44% 43
2013
Q4 		$32.1M Buy
604,900
+37,300
+7% +$1.9M 0.3% 76
2013
Q3 		$26.3M Sell
567,600
-76,200
-12% -$3.34M 0.28% 86
2013
Q2 		$28.8M Buy
+643,800
New +$28M 0.34% 64

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Korea Investment Corp's BMY Position: Q1 2026 in Review

Korea Investment Corp increased its Bristol-Myers Squibb (BMY) stake by 14% in Q1 2026, buying an estimated $12.2M and bringing the position to 1,703,989 shares worth $103M. The position accounts for 0.21% of the portfolio, ranked #81.

Korea Investment Corp first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $164M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Korea Investment Corp held 1,703,989 shares of Bristol-Myers Squibb worth $103M as of Q1 2026.
  • Korea Investment Corp bought 209,534 Bristol-Myers Squibb shares in Q1 2026, an estimated $12.2M.
  • Bristol-Myers Squibb made up 0.21% of Korea Investment Corp's portfolio in Q1 2026, its #81 holding.
  • Korea Investment Corp first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Korea Investment Corp's Bristol-Myers Squibb position peaked at $164M in Q2 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Korea Investment Corp's 13F filing for Q1 2026, filed 13 May 2026.